The 12th Congress of Zhejiang Federation of Industry and Commerce Held in Hangzhou Chairman Jiang Xiaomeng Re-elected Vice President of Provincial Chamber of Commerce
Release time:
2022-09-01
8# January 18 to 19 , the 12th Congress of Zhejiang Federation of Industry and Commerce was held in Hangzhou to elect the 12th leadership of the Provincial Federation of Industry and Commerce. Jiang Xiaomeng, Secretary of the Party Committee and Chairman of the Group, was re-elected as Vice President of Zhejiang Chamber of Commerce. Yuan Jiajun, Secretary of Zhejiang provincial Party committee and director of the Standing Committee of the provincial people's Congress, attended the opening ceremony and delivered a speech. Wang Hao, Deputy Secretary of the Zhejiang Provincial Party Committee and Governor, Huang Jianfa, Deputy Secretary of the Provincial Party Committee and Secretary of the Provincial Political and Legal Committee, Xu Luode, Member of the Standing Committee of the Provincial Party Committee, Secretary of the Provincial Commission for Discipline Inspection, and Director of the Provincial Supervision Committee, Chen Yijun, Member of the Standing Committee of the Provincial Party Committee, Minister of the United Front Work Department Qiu Qiwen, Member of the Standing Committee of the Provincial Party Committee and Minister Wang Gang, and Minister of the Propaganda Department, and Deputy. In his speech, Yuan Jiajun fully affirmed the work achievements of the Provincial Federation of Industry and Commerce in the past five years, stressed the need to thoroughly implement the spirit of General Secretary Xi Jinping's important exposition on the development of the private economy and the work of the Federation of Industry and Commerce, fully implement the arrangements of the Central United Front work Conference, focus on the objectives and tasks set by the 15th Party Congress of Zhejiang Province, and adhere to the "two unwavering", further strengthen self-construction, identify action coordinates, assume responsibilities and missions, do a good job in service guarantees, make every effort to promote the "two health", make every effort to promote the innovative development and comprehensive development of the Zhejiang Federation of Industry and Commerce in the new era, and help the new leap of the private economy in the new era. Make greater contributions to faithfully practicing the "August 8 Strategy", resolutely achieving the "two safeguards", and striving to promote the "two firsts"; hope that the majority of Zhejiang businessmen will stick to love the party, strengthen confidence, create the future, strengthen direction, innovate and win, adhere to the example of inheritance and righteousness first; emphasize that party committees at all levels in the province should strengthen leadership over the work of the Federation of Industry and Commerce, study and solve difficult problems in a timely manner, and effectively create a good environment for the development of the private economy And conditions.
The conference reviewed and approved the work report of the 11th Executive Committee of the Zhejiang Federation of Industry and Commerce and related resolutions, elected the 12th Executive Committee and Standing Committee of the Provincial Federation of Industry and Commerce, and elected the Provincial Federation of Industry and Commerce (Provincial Chamber of Commerce) The new leadership team. Jiang Xiaomeng, secretary of the party committee and chairman of the board of directors of the group company, was elected as the vice president of Zhejiang Chamber of Commerce. This is also his re-election as Vice-President since the last General Assembly.
was re-elected as the vice president of the Provincial Chamber of Commerce. Jiang Xiaomeng said that this fully reflects the government and all sectors of society's affirmation of Jianfeng Group's operating performance and social contributions in recent years, and further stimulates self-confidence and courage in the company's future development., And strive to make the company make greater contributions in vigorously promoting"two health" and striving to promote "two first.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page